<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>981</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>8725098</PubmedId>
            <Abstract>Antigenic site D from the spike protein of transmissible gastroenteritis virus (TGEV), which is a continuous epitope critical in neutralization, has been expressed as a fusion protein with E. coli heat-labile toxin B subunit (LT-B) in attenuated S. typhimurium. Synthetic peptides containing the sequence of site D induced TGEV neutralizing antibodies when inoculated subcutaneously in both rabbits and swine. A synthetic oligonucleotide encoding residues 373-398 of TGEV S protein, including antigenic site D, was cloned in frame with the 3' end of LT-B gene, into a plasmid used to transform S. typhimurium delta asd chi 3730. A collection of 6 recombinant plasmids designated pYALTB-D I-VI encoding LTB-site D fusions with a variable number of site D sequences were selected. Four of the 6 LTB-site D fusion products expressed in S. typhimurium chi 3730 formed oligomers (pentamers) that dissociated at &gt; 70 degrees. S. typhimurium chi 3730 (pYALTB-D) V and VI expressed the oligomer forming products with higher antigenicity. Partially purified LTB-site D fusion product expressed from S. typhimurium chi 3730 (pYALTB-D) V induced anti-TGEV neutralizing antibodies in rabbits. Recombinant vaccine strain S. typhimurium delta cya delta crp delta asd chi 3987 transformed with plasmid pYALTB-D V expressed constitutively products that formed oligomers presumably containing 20 copies of site D, and showed a high stability in vitro. This recombinant strain was orally inoculated in rabbits and induced TGEV specific antibodies in both serum and intestinal secretion.</Abstract>
            <ArticleYear>1996</ArticleYear>
            <ArticlePages>1-9</ArticlePages>
            <ArticleTitle>A continuous epitope from transmissible gastroenteritis virus S protein fused to E. coli heat-labile toxin B subunit expressed by attenuated Salmonella induces serum and secretory immunity.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Smerdou</LastName>
                    <ForeName>C</ForeName>
                </Author>
                <Author>
                    <LastName>Anton</LastName>
                    <ForeName>I M</ForeName>
                </Author>
                <Author>
                    <LastName>Plana</LastName>
                    <ForeName>J</ForeName>
                </Author>
                <Author>
                    <LastName>Curtiss</LastName>
                    <ForeName>R</ForeName>
                    <Suffix>3rd</Suffix>
                </Author>
                <Author>
                    <LastName>Enjuanes</LastName>
                    <ForeName>L</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Molecular and Cell Biology, Centro Nacional de Biotecnologia, CSIC, Madrid, Spain.</Affiliations>
            <ArticleChemicalList>Antibodies, Viral;Bacterial Toxins;DNA, Viral;Enterotoxins;Epitopes, B-Lymphocyte;Escherichia coli Proteins;MHV surface projection glycoprotein;Membrane Glycoproteins;Recombinant Fusion Proteins;Spike Glycoprotein, Coronavirus;Viral Envelope Proteins;heat-labile enterotoxin, E coli;spike glycoprotein, SARS-CoV</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Antibodies, Viral(immunology); Bacterial Toxins(genetics; immunology); Base Sequence; DNA, Viral; Enterotoxins(genetics; immunology); Epitopes, B-Lymphocyte(genetics; immunology); Escherichia coli Proteins; Gene Expression; Membrane Glycoproteins(genetics; immunology); Molecular Sequence Data; Neutralization Tests; Rabbits; Recombinant Fusion Proteins(genetics; immunology); Salmonella typhimurium; Spike Glycoprotein, Coronavirus; Swine; Transmissible gastroenteritis virus(genetics; immunology); Viral Envelope Proteins(genetics; immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>41</Volume>
                <Issue>1</Issue>
                <Title>Virus research</Title>
                <Issn>1872-7492</Issn>
                <MedlineTa>Virus Res</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>peptide D</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>CYTVSDSSFFSYGEIPFGVTDGPRYC</LinearSequence>
                        <StartingPosition>373</StartingPosition>
                        <EndingPosition>398</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P07946.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11151</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>P. 2</LocationOfData>
                <EpitopeId>7445</EpitopeId>
                <ReferenceStartingPosition>373</ReferenceStartingPosition>
                <ReferenceEndingPosition>398</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3B</LocationOfData>
                        <BCellId>12043</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>2 mo</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>CYTVSDSSFFSYGEIPFGVTDGPRYC</LinearSequence>
                                            <StartingPosition>373</StartingPosition>
                                            <EndingPosition>398</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P07946.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11151</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>3 repeats of epitope</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <RecombinantOrganism>
                                        <SubType>Recombinant Organism</SubType>
                                    </RecombinantOrganism>
                                </ImmunogenContainingObject>
                                <Route>Oral</Route>
                                <DoseSchedule>Days 1, 5, 10, 40</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The immunogen was an attentuated Salmonella typhimurium strain, &lt;SUB&gt;&amp;ch8;&lt;/SUB&gt;3987, carrying the p YALTB-D V plasmid which contains three repeats of the epitope sequence fused to the C-terminal of the E. coli heat-labile toxin subunit B. This strain constitutively expresses the fusion product. .</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>33.3</ResponseFrequency>
                            <AssayComments>At 50 days post-inoculation, intestinal secretion from the immunized animals was sampled and assayed by RIA. The demonstration of induction of secretory immunity in swine with this recombinant vector is important because an effective vaccine against transmissible gastroenteritis virus requires secretory immunity. The E. coli heat-labile toxin B subunit was chosen as the basis for the fusion protein because it is responsible for binding to the surface of intestinal epithelial cells and is known as a potent oral immunogen which can function as an oral adjuvant eliciting high-titer serum and secretory antibodies.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Other</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>Intestinal secretion</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>sIgA</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Porcine transmissible gastroenteritis coronavirus</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>11151</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3B</LocationOfData>
                        <BCellId>12042</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>2 mo</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>CYTVSDSSFFSYGEIPFGVTDGPRYC</LinearSequence>
                                            <StartingPosition>373</StartingPosition>
                                            <EndingPosition>398</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P07946.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11151</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>3 repeats of epitope</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <RecombinantOrganism>
                                        <SubType>Recombinant Organism</SubType>
                                    </RecombinantOrganism>
                                </ImmunogenContainingObject>
                                <Route>Oral</Route>
                                <DoseSchedule>Days 1, 5, 10, 40</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The immunogen was an attentuated Salmonella typhimurium strain, &lt;SUB&gt;&amp;ch8;&lt;/SUB&gt;3987, carrying the p YALTB-D V plasmid which contains three repeats of the epitope sequence fused to the C-terminal of the E. coli heat-labile toxin subunit B. This strain constitutively expresses the fusion product. .</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>At 50 days post-inoculation, intestinal secretion from the immunized animals was sampled and assayed by RIA.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Other</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>Intestinal secretion</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Porcine transmissible gastroenteritis coronavirus</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>11151</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <BCellId>12028</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>2 mo</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>CYTVSDSSFFSYGEIPFGVTDGPRYC</LinearSequence>
                                            <StartingPosition>373</StartingPosition>
                                            <EndingPosition>398</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P07946.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11151</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>3 repeats of epitope</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Other</Route>
                                <DoseSchedule>Day 1 (with FCA),  day 17  (IFA),  day 32 (IFA)</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>pYALTB-D V is a plasmid containing three repeats of the epitope sequence fused to the C-terminal of the E. coli heat-labile toxin subunit B. pYALTB-D V expression product was partially purified from a culture of S. typhimurium χ&lt;SUP&gt;3730&lt;/SUP&gt; induced with isopropyl β-D-thiogalactopyranoside (IPTG) and used to inoculate rabbits by subcutaneous, intradermal and intramuscular routes. .</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>316</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Samples of sera were taken on day 39 post-inoculation and assayed by neutralization of viral infectivity.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>Serum</AssayedAntibodyName>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Porcine transmissible gastroenteritis coronavirus</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>11151</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 1</LocationOfData>
                        <BCellId>12005</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>2 mo</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>CYTVSDSSFFSYGEIPFGVTDGPRYC</LinearSequence>
                                            <StartingPosition>373</StartingPosition>
                                            <EndingPosition>398</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P07946.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11151</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Cyclic monomer of peptide D</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Day 1 (with FCA), day 35 (peptide), day 57 (peptide)</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The immunogen was a cyclic monomer of Peptide D formed via a disulfide bridge by the oxidation of the N- and C-terminal cysteines with (NH&lt;SUB&gt;4&lt;/SUB&gt;)&lt;SUB&gt;2&lt;/SUB&gt;CO&lt;SUB&gt;3&lt;/SUB&gt;.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Samples of sera were taken on day 65 post-inoculation and assayed by RIA. The RIA test was also positive when conducted with peptide D as the antigen.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>Serum</AssayedAntibodyName>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Porcine transmissible gastroenteritis coronavirus</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>11151</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 1</LocationOfData>
                        <BCellId>12009</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000188</OrganismId>
                                <Age>2 mo</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>CYTVSDSSFFSYGEIPFGVTDGPRYC</LinearSequence>
                                            <StartingPosition>373</StartingPosition>
                                            <EndingPosition>398</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P07946.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11151</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Cyclic monomer of peptide D</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Day 1 (with FCA), day 35 (peptide), day 57 (peptide)</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The immunogen was a cyclic monomer of Peptide D formed via a disulfide bridge by the oxidation of the N- and C-terminal cysteines with (NH&lt;SUB&gt;4&lt;/SUB&gt;)&lt;SUB&gt;2&lt;/SUB&gt;CO&lt;SUB&gt;3&lt;/SUB&gt;.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>316</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Samples of sera were taken on day 65 post-inoculation and assayed for neutralizing activity against transmissible gastroenteritis virus.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>Serum</AssayedAntibodyName>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Porcine transmissible gastroenteritis coronavirus</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>11151</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <BCellId>12011</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>2 mo</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>CYTVSDSSFFSYGEIPFGVTDGPRYC</LinearSequence>
                                            <StartingPosition>373</StartingPosition>
                                            <EndingPosition>398</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P07946.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11151</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>3 repeats of epitope</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Other</Route>
                                <DoseSchedule>Day 1 (with FCA),  day 17  (IFA),  day 32 (IFA)</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>pYALTB-D V is a plasmid containing three repeats of the epitope sequence fused to the C-terminal of the E. coli heat-labile toxin subunit B. pYALTB-D V expression product was partially purified from a culture of S. typhimurium χ&lt;SUP&gt;3730&lt;/SUP&gt; induced with isopropyl β-D-thiogalactopyranoside (IPTG) and used to inoculate rabbits by subcutaneous, intradermal and intramuscular routes. .</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Samples of sera were taken on day 39 post-inoculation and assayed by RIA. The RIA test was also positive when conducted with peptide D as the antigen.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>Serum</AssayedAntibodyName>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Porcine transmissible gastroenteritis coronavirus</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>11151</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3A</LocationOfData>
                        <BCellId>12038</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>2 mo</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>CYTVSDSSFFSYGEIPFGVTDGPRYC</LinearSequence>
                                            <StartingPosition>373</StartingPosition>
                                            <EndingPosition>398</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P07946.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11151</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>3 repeats of epitope</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <RecombinantOrganism>
                                        <SubType>Recombinant Organism</SubType>
                                    </RecombinantOrganism>
                                </ImmunogenContainingObject>
                                <Route>Oral</Route>
                                <DoseSchedule>Days 1, 5, 10, 40</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The immunogen was an attentuated Salmonella typhimurium strain, &lt;SUB&gt;&amp;ch8;&lt;/SUB&gt;3987, carrying the p YALTB-D V plasmid which contains three repeats of the epitope sequence fused to the C-terminal of the E. coli heat-labile toxin subunit B. This strain constitutively expresses the fusion product. .</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>33.3</ResponseFrequency>
                            <AssayComments>Samples of sera were taken on day 50 post-inoculation and assayed by RIA.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>Serum</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Porcine transmissible gastroenteritis coronavirus</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>11151</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 1</LocationOfData>
                        <BCellId>12008</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                                <Age>2 mo</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>CYTVSDSSFFSYGEIPFGVTDGPRYC</LinearSequence>
                                            <StartingPosition>373</StartingPosition>
                                            <EndingPosition>398</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P07946.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11151</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Cyclic monomer of peptide D</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Day 1 (with FCA), day 35 (peptide), day 57 (peptide)</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The immunogen was a cyclic monomer of Peptide D formed via a disulfide bridge by the oxidation of the N- and C-terminal cysteines with (NH&lt;SUB&gt;4&lt;/SUB&gt;)&lt;SUB&gt;2&lt;/SUB&gt;CO&lt;SUB&gt;3&lt;/SUB&gt;.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>316</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Samples of sera were taken on day 65 post-inoculation and assayed for neutralizing activity against transmissible gastroenteritis virus.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>Serum</AssayedAntibodyName>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Porcine transmissible gastroenteritis coronavirus</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>11151</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 1</LocationOfData>
                        <BCellId>12007</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000188</OrganismId>
                                <Age>2 mo</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>CYTVSDSSFFSYGEIPFGVTDGPRYC</LinearSequence>
                                            <StartingPosition>373</StartingPosition>
                                            <EndingPosition>398</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P07946.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11151</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Cyclic monomer of peptide D</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Day 1 (with FCA), day 35 (peptide), day 57 (peptide)</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The immunogen was a cyclic monomer of Peptide D formed via a disulfide bridge by the oxidation of the N- and C-terminal cysteines with (NH&lt;SUB&gt;4&lt;/SUB&gt;)&lt;SUB&gt;2&lt;/SUB&gt;CO&lt;SUB&gt;3&lt;/SUB&gt;.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>199</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Samples of sera were taken on day 65 post-inoculation and assayed by RIA. The RIA test was also positive when conducted with peptide D as the antigen.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>Serum</AssayedAntibodyName>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Porcine transmissible gastroenteritis coronavirus</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>11151</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

